Creative Financial Designs’s BioMarin Pharmaceuticals BMRN Stock Holding History

Creative Financial Designs’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$282	Hold	5	–	–	﹤0.01%	2064
2025 Q4	$297	Hold	5	–	–	﹤0.01%	1963
2025 Q3	$271	Buy	+5	New	+$286	﹤0.01%	1964
2021 Q4	–	Sell	-136	Closed	-$11K	–	1230
2021 Q3	$11K	Hold	136	–	–	﹤0.01%	988
2021 Q2	$11K	Hold	136	–	–	﹤0.01%	992
2021 Q1	$10K	Hold	136	–	–	﹤0.01%	928
2020 Q4	$12K	Hold	136	–	–	﹤0.01%	819
2020 Q3	$10K	Buy	136 +106	+353%	+$10.7K	﹤0.01%	796
2020 Q2	$4K	Buy	+30	New	+$2.98K	﹤0.01%	897

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Creative Financial Designs's BMRN Position: Q1 2026 in Review

Creative Financial Designs held its BioMarin Pharmaceuticals (BMRN) position steady in Q1 2026 at 5 shares worth $282. The position accounts for ﹤0.01% of the portfolio, ranked #2064.

Creative Financial Designs first reported a position in BMRN in Q2 2020 and has held it in 9 quarters since. The position peaked at $12K in Q4 2020. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

Creative Financial Designs held 5 shares of BioMarin Pharmaceuticals worth $282 as of Q1 2026.
Creative Financial Designs left its BioMarin Pharmaceuticals share count unchanged in Q1 2026.
BioMarin Pharmaceuticals made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #2064 holding.
Creative Financial Designs first reported a position in BioMarin Pharmaceuticals in Q2 2020 and has held it in 9 quarters since.
Creative Financial Designs's BioMarin Pharmaceuticals position peaked at $12K in Q4 2020.
554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.